Reports on the FDA's planning, performance, budgeting, user fee programs, and other agency-wide programs
- Strategic Priorities
Cross-cutting strategic priorities and core mission goals and objectives, 2014 - 2018
- FDA Innovation Initiative
Redoubling the agency’s efforts to encourage innovations that will promote public health as well as strengthen the American economy.
Annual and multi-year budgeting documents in support of the nationwide public health protection programs administered by FDA.
- Risk Communication Reports
FDA's Strategic Plan for Risk Communication and the book "Communicating Risks and Benefits: An Evidence-Based User's Guide," a report from FDA's Advisory Committee for Risk Communication and consultants showing how to incorporate and build on risk communication-related research.
- User Fee Reports
Performance and financial reports on implementation of user fee programs supporting the review of human and animal drugs, biologics, and medical devices
- Performance Reports
Reports on the review process for combination products
- Performance Plans
Performance measurement and reporting documents
- Economic Analyses
Economic analyses of important proposed and final regulations issued by the Food and Drug Administration.